文献速递心脑血管急症复苏、休克与脓毒症

COVID-19疫情期间院外心脏骤停的发生率与结局:系统评价与Meta分析

Incidence and outcome of out-of-hospital cardiac arrests in the COVID-19 era: A systematic review and meta-analysis.
PubMed 文献 · Resuscitation · 2020-11-01
一句话结论Meta分析显示COVID-19疫情期间院外心脏骤停发生率升高120%、死亡率更高,复苏操作(AED使用、插管、ROSC、存活出院)均更少。

该研究系统检索PubMed、EMBASE及预印本网站,纳入10项在同一辖区比较疫情前与疫情期间院外心脏骤停(OHCA)数据的研究,共35,379例OHCA事件。结果显示疫情期间OHCA事件增加120%,OHCA至救护车到达时间更长(p=0.036);疫情期间死亡率更高(OR=0.67,95%CI 0.49-0.91),声门上气道使用更多(OR=0.36,95%CI 0.27-0.46),而AED使用(OR=1.78,95%CI 1.06-2.98)、ROSC(OR=1.63,95%CI 1.18-2.26)和插管(OR=1.87,95%CI 1.12-3.13)在疫情前更常见;疫情前更多患者存活至入院(OR=1.75,95%CI 1.42-2.17)和出院(OR=1.65,95%CI 1.28-2.12)。旁人心肺复苏、无人目击OHCA、急救人员复苏尝试和机械心肺复苏设备使用无显著差异。结论认为疫情期间OHCA发生率和死亡率更高,复苏实践存在显著变化,亟需研究确定大流行期间最佳院前救治流程。

要点

  • 疫情期间OHCA事件增加120%,OHCA至救护车到达时间更长(p=0.036)。
  • 疫情期间死亡率更高(OR=0.67,95%CI 0.49-0.91),存活至入院(OR=1.75,95%CI 1.42-2.17)和出院(OR=1.65,95%CI 1.28-2.12)在疫情前更常见。
  • 疫情前AED使用(OR=1.78,95%CI 1.06-2.98)、ROSC(OR=1.63,95%CI 1.18-2.26)和插管(OR=1.87,95%CI 1.12-3.13)更常见,疫情期间声门上气道使用更多(OR=0.36,95%CI 0.27-0.46)。
  • 旁人心肺复苏(OR=1.18,95%CI 0.95-1.46)、无人目击OHCA(OR=0.84,95%CI 0.66-1.07)、急救人员复苏尝试(OR=1.19,95%CI 1.00-1.42)和机械心肺复苏设备使用(OR=1.57,95%CI 0.55-4.55)无显著差异。

适用人群与场景

  • 同一辖区内疫情前与疫情期间发生院外心脏骤停(OHCA)的患者,数据来自10项研究共35,379例OHCA事件。

研究设计与关键结果

  • 系统评价与Meta分析,纳入10项报告同一辖区疫情前与疫情期间OHCA比较数据的研究,共35,379例OHCA事件,研究质量采用Newcastle-Ottawa量表评估。
  • 疫情期间OHCA事件增加120%;OHCA至救护车到达时间在疫情期间更长(p=0.036)。
  • 疫情期间死亡率更高(OR=0.67,95%CI 0.49-0.91);疫情前存活至入院(OR=1.75,95%CI 1.42-2.17)和存活至出院(OR=1.65,95%CI 1.28-2.12)更常见。
  • 疫情前AED使用(OR=1.78,95%CI 1.06-2.98)、ROSC(OR=1.63,95%CI 1.18-2.26)和插管(OR=1.87,95%CI 1.12-3.13)更常见;疫情期间声门上气道使用更多(OR=0.36,95%CI 0.27-0.46)。
  • 旁人心肺复苏(OR=1.18,95%CI 0.95-1.46)、无人目击OHCA(OR=0.84,95%CI 0.66-1.07)、急救人员复苏尝试(OR=1.19,95%CI 1.00-1.42)和机械心肺复苏设备使用(OR=1.57,95%CI 0.55-4.55)在疫情前后无显著差异。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,研究质量基于Newcastle-Ottawa量表评估。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,亟需研究确定大流行期间最佳院前救治流程。

指南或共识出处

  • PROSPERO注册号CRD42020203371。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The impact of COVID-19 on pre-hospital and hospital services and hence on the prevalence and outcomes of out-of-hospital cardiac arrests (OHCA) remain unclear. The review aimed to evaluate the influence of the COVID-19 pandemic on the incidence, process, and outcomes of OHCA.

METHODS: A systematic review of PubMed, EMBASE, and pre-print websites was performed. Studies reporting comparative data on OHCA within the same jurisdiction, before and during the COVID-19 pandemic were included. Study quality was assessed based on the Newcastle-Ottawa Scale.

RESULTS: Ten studies reporting data from 35,379 OHCA events were included. There was a 120% increase in OHCA events since the pandemic. Time from OHCA to ambulance arrival was longer during the pandemic (p = 0.036). While mortality (OR = 0.67, 95%-CI 0.49-0.91) and supraglottic airway use (OR = 0.36, 95%-CI 0.27-0.46) was higher during the pandemic, automated external defibrillator use (OR = 1.78 95%-CI 1.06-2.98), return of spontaneous circulation (OR = 1.63, 95%CI 1.18-2.26) and intubation (OR = 1.87, 95%-CI 1.12--3.13) was more common before the pandemic. More patients survived to hospital admission (OR = 1.75, 95%-CI 1.42-2.17) and discharge (OR = 1.65, 95%-CI 1.28-2.12) before the pandemic. Bystander CPR (OR = 1.18, 95%-CI 0.95-1.46), unwitnessed OHCA (OR = 0.84, 95%-CI 0.66-1.07), paramedic-resuscitation attempts (OR = 1.19 95%-CI 1.00-1.42) and mechanical CPR device use (OR = 1.57 95%-CI 0.55-4.55) did not defer significantly.

CONCLUSIONS: The incidence and mortality following OHCA was higher during the COVID-19 pandemic. There were significant variations in resuscitation practices during the pandemic. Research to define optimal processes of pre-hospital care during a pandemic is urgently required.

REVIEW REGISTRATION: PROSPERO (CRD42020203371).

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Lim ZJ, Ponnapa Reddy M, Afroz A, et al. Incidence and outcome of out-of-hospital cardiac arrests in the COVID-19 era: A systematic review and meta-analysis. Resuscitation. 2020. PMID: 33137418. doi:10.1016/j.resuscitation.2020.10.025

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。